KORU Medical Systems (KRMD)
Builds mechanical infusion systems for at-home subcutaneous biologic delivery.
$3.31
At close+0.00 (+0.15%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7 | 7 | 8 | 8 | 8 | 9 | 10 | 10 | 10 | 11 | 12 | 12 |
| Cost of revenue | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 4 |
| Gross profit | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 | 7 | 8 |
| 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 7 | |
| Research & development | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 6 | 6 | 7 | 6 | |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| Other expenses | 5 | 5 | 6 | 6 | 0 | 6 | 6 | 6 | 0 | 0 | 0 | 0 |
| Operating income | −2 | −2 | −2 | −1 | −2 | −2 | −1 | 0 | −1 | −1 | −1 | 1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −2 | −2 | −2 | −1 | −2 | −2 | −1 | 0 | −1 | 0 | −1 | 0 |
| Income tax expense | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −1 | −7 | −2 | −1 | −2 | −2 | −1 | 0 | −1 | 0 | −1 | 0 |
| Net income | −1 | −7 | −2 | −1 | −2 | −2 | −1 | 0 | −1 | 0 | −1 | 0 |
| EPS, basic | −$0.03 | −$0.16 | −$0.04 | −$0.02 | −$0.03 | −$0.03 | −$0.03 | −$0.00 | −$0.02 | −$0.01 | −$0.02 | $0.01 |
| EPS, diluted | −$0.03 | −$0.16 | −$0.04 | −$0.02 | −$0.03 | −$0.03 | −$0.03 | −$0.00 | −$0.02 | −$0.01 | −$0.02 | $0.01 |
| Weighted average shares, basic | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 |
| Weighted average shares, diluted | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 50 |
| EBITDA | −2 | −2 | −2 | −1 | −1 | −1 | −1 | 0 | −1 | 0 | −1 | 0 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −2 | −2 | −2 | −1 | −2 | −2 | −1 | 0 | −1 | 0 | −1 | 0 |
